• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 12320
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Reaction (2414); Cough (4457)
Event Date 08/20/2020
Event Type  Injury  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that 15 minutes into a continuous mononuclear cell (cmnc) collection procedure, a patient with lymphoma began to cough.The physician ordered to stop the procedure and to push 50mg iv benadryl, due to possible eto reaction.Prior to the procedrue, the patient was stable with a heart rate of 120bpm.The customer declined to provide the patient identifier and age.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in h6 & h10.Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.A disposable search history was performed for this lot.No additional reports of similar issues were found.According to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Symptoms of these allergic reactions may include hives, dyspnea, wheezing, burning eyes, tachycardia, hypotension, and or facial swelling and flushing.Mild reactions can be treated with diphenhydramine administered through an iv.Investigation is in process.A follow up report will be provided.
 
Manufacturer Narrative
Investigation: per the customer, they will perform a saline rinse before the next cmnc procedure.Root cause: based on customer's statements about the allergic reaction and the literature review, the cause for the patient's reaction was a result of her sensitivity to eto.
 
Event Description
Per the customer, the patient is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key10522377
MDR Text Key206550607
Report Number1722028-2020-00441
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583123205
UDI-Public05020583123205
Combination Product (y/n)N
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2022
Device Model Number12320
Device Catalogue Number12320
Device Lot Number2002243130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 08/20/2020
Initial Date FDA Received09/11/2020
Supplement Dates Manufacturer Received10/01/2020
10/07/2020
Supplement Dates FDA Received10/06/2020
10/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight75
-
-